<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1025-028X</journal-id>
<journal-title><![CDATA[Vaccimonitor]]></journal-title>
<abbrev-journal-title><![CDATA[Vaccimonitor]]></abbrev-journal-title>
<issn>1025-028X</issn>
<publisher>
<publisher-name><![CDATA[Finlay Ediciones]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1025-028X2000000300001</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Genes HLA en una muestra de la población cubaGenes cubana]]></article-title>
<article-title xml:lang="en"><![CDATA[HLA genes in a sample of the Cuban population]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paradoa]]></surname>
<given-names><![CDATA[Martha L]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Middleton]]></surname>
<given-names><![CDATA[Derek]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[Armando]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sarmiento]]></surname>
<given-names><![CDATA[María E]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Leyva]]></surname>
<given-names><![CDATA[Jorge]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Hospital Pediátrico J.M. Márquez  ]]></institution>
<addr-line><![CDATA[Ciudad de La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Northern Ireland Regional Histocompatibility and Immunogenetics Laboratory  ]]></institution>
<addr-line><![CDATA[North Ireland ]]></addr-line>
<country>UK</country>
</aff>
<aff id="A03">
<institution><![CDATA[,Instituto Finlay  ]]></institution>
<addr-line><![CDATA[Ciudad de La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2000</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2000</year>
</pub-date>
<volume>9</volume>
<numero>3</numero>
<fpage>1</fpage>
<lpage>5</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1025-028X2000000300001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1025-028X2000000300001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1025-028X2000000300001&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Los antígenos codificados por los genes HLA tienen una gran importancia para el trasplante así como constituyen marcadores genéticos para estudios antropológicos y están asociados a diversas enfermedades en cuya etiopatogenia pueden estar involucrados mecanismos inmunológicos. En este estudio se determina la distribución de los alelos HLA en la población cubana de Ciudad de La Habana, como área cosmopolita. Fueron tipados 129 donantes de sangre sanos (70 blancos, 42 mestizos y 17 negros) por la técnica de tipaje de ADN para los alelos HLA -A, B, C y DRB1 mediante PCR y tipaje de oligonucleótidos. El análisis de la frecuencia génica (FG) de cada locus mostró los resultados siguientes: HLA -A * 0201 (12,3%),* 0301 (8,07%), * 2301 (7,8%), * 2402 (7,8%), * 0101 (6,7%) y * 2902 (6,4%): HLA - B * 35 (9,7%), B * 44 (9,33%), B * 07 (8,89%) y B * 53 (7,6%): HLA - C * 04 (17,35%),* 07 (15,5%),* 0702 (7,20%), * 0602 (6,77) y *0802 (5,9%): HLA - DR * 02 (14,61%),* 04 (14,1%), * 0701 (12,82%), * 0103 (12,25%), * 03 (11,9%), * 11 (11,9%), * 13 (11,51%) y * 01 (6,72%). Se encontró una frecuencia elevada en la distribución de un grupo de alelos, lo que podría estar en relación con ciertas combinaciones que confieran ventajas evolutivas contra patógenos, respondiendo a los llamados genes de protección para ciertas enfermedades en nuestra población.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[The antigens coded by the HLA genes have a great importance in transplantation, and as genetic markers for anthropological studies, and they are associated to diverse illnesses, in whose pathogenic immunology mechanisms they could be involved. In this study, the distribution of HLA alleles was determined in the Cuban population of Havana City, as a cosmopolitan area 129 healthy blood donors were studied (70 whites, 42 mixed blood (black x white) and 17 blacks), by DNA typing for HLA-A, B, C and DRB1 alleles using PCR and oligonucleotide typing. The gene frequency analysis (GF) of each locus showed the following results: HLA-A * 0201 (23,2%), * 0301 (15,5%), * 2301 (14,7%), * 2402 (14,7%), * 0101 (13,1%) and * 2902 (12,4%): HLA-B * 35 (18,6%), * 44 (17,8%), * 07 (17%) and * 53 (14,7%): HLA-C * 04 (31,7%), * 07 (28,6%), * 0702 (13,9%), * 0602 (13.1) and * 0802 (11,6%): HLA-DR * 02 (27,1%), * 04 (26,3%), * 03 (22,4%), * 11 (22,4%), * 13 (21,7%) and * 01 (13,9%). A high frequency in the distribution of a group of alleles was found. This fact could be related to combinations that give evolutionary advantages against pathogens in our population.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[HLA]]></kwd>
<kwd lng="es"><![CDATA[genes]]></kwd>
<kwd lng="es"><![CDATA[alelos]]></kwd>
<kwd lng="es"><![CDATA[población]]></kwd>
<kwd lng="en"><![CDATA[HLA]]></kwd>
<kwd lng="en"><![CDATA[genes]]></kwd>
<kwd lng="en"><![CDATA[allele]]></kwd>
<kwd lng="en"><![CDATA[population]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><strong>ARTICULOS ORIGINALES</strong></font></p>     <p align="right">&nbsp;</p>     <p align="right"><font size="4" face="Verdana, Arial, Helvetica, sans-serif"><strong>Genes HLA en una muestra de la poblaci&oacute;n cubaGenes cubana.</strong></font></p>     <p align="right">&nbsp;</p>     <p align="right"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong><font size="3">HLA genes in a sample of the Cuban population.</font>    <br> </strong></font></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>Martha L. Paradoa1, Derek Middleton2 , Armando Acosta3, Mar&iacute;a E. Sarmiento3, Jorge Leyva3.</strong>    <br>   </font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Hospital Pedi&aacute;trico &ldquo;J.M. M&aacute;rquez&rdquo;. Ciudad de La Habana, Cuba.Email:<a href="emailto:mparadoa@infomed.sld.cu">mparadoa@infomed.sld.cu</a>    ]]></body>
<body><![CDATA[<br>   2. Northern Ireland Regional Histocompatibility and Immunogenetics Laboratory, City Hospital. Belfast. North Ireland, UK.    <br>   3. Instituto Finlay, Centro de Investigaci&oacute;n-Producci&oacute;n de Vacunas y Sueros. Ciudad de La Habana, Cuba.    <br> </font></p> <hr>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>RESUMEN</strong> </font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Los ant&iacute;genos codificados por los genes HLA tienen una gran importancia para el trasplante as&iacute; como    constituyen marcadores gen&eacute;ticos para estudios antropol&oacute;gicos y est&aacute;n asociados a diversas enfermedades en    cuya etiopatogenia pueden estar involucrados mecanismos inmunol&oacute;gicos. En este estudio se determina la    distribuci&oacute;n de los alelos HLA en la poblaci&oacute;n cubana de Ciudad de La Habana, como &aacute;rea cosmopolita. Fueron    tipados 129 donantes de sangre sanos (70 blancos, 42 mestizos y 17 negros) por la t&eacute;cnica de tipaje de ADN    para los alelos HLA &ndash;A, B, C y DRB1 mediante PCR y tipaje de oligonucle&oacute;tidos. El an&aacute;lisis de la frecuencia    g&eacute;nica (FG) de cada locus mostr&oacute; los resultados siguientes: HLA &ndash;A * 0201 (12,3%),* 0301 (8,07%), * 2301    (7,8%), * 2402 (7,8%), * 0101 (6,7%) y * 2902 (6,4%): HLA &ndash; B * 35 (9,7%), B * 44 (9,33%), B * 07 (8,89%) y B *    53 (7,6%): HLA &ndash; C * 04 (17,35%),* 07 (15,5%),* 0702 (7,20%), * 0602 (6,77) y *0802 (5,9%): HLA &ndash; DR * 02    (14,61%),* 04 (14,1%), * 0701 (12,82%), * 0103 (12,25%), * 03 (11,9%), * 11 (11,9%), * 13 (11,51%) y * 01    (6,72%). Se encontr&oacute; una frecuencia elevada en la distribuci&oacute;n de un grupo de alelos, lo que podr&iacute;a estar en    relaci&oacute;n con ciertas combinaciones que confieran ventajas evolutivas contra pat&oacute;genos, respondiendo a los    llamados genes de protecci&oacute;n para ciertas enfermedades en nuestra poblaci&oacute;n.    <br>   </font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>Palabras claves:</strong> HLA, genes, alelos, poblaci&oacute;n.</font></p> <hr>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">  <strong>ABSTRACT</strong></font></p>     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> The antigens coded by the HLA genes have a great importance in transplantation, and as genetic markers for    anthropological studies, and they are associated to diverse illnesses, in whose pathogenic immunology    mechanisms they could be involved. In this study, the distribution of HLA alleles was determined in the Cuban    population of Havana City, as a cosmopolitan area 129 healthy blood donors were studied (70 whites, 42    mixed blood (black x white) and 17 blacks), by DNA typing for HLA&ndash;A, B, C and DRB1 alleles using PCR and    oligonucleotide typing. The gene frequency analysis (GF) of each locus showed the following results: HLA&ndash;A *    0201 (23,2%), * 0301 (15,5%), * 2301 (14,7%), * 2402 (14,7%), * 0101 (13,1%) and * 2902 (12,4%): HLA&ndash;B *    35 (18,6%), * 44 (17,8%), * 07 (17%) and * 53 (14,7%): HLA&ndash;C * 04 (31,7%), * 07 (28,6%), * 0702 (13,9%), *    0602 (13.1) and * 0802 (11,6%): HLA&ndash;DR * 02 (27,1%), * 04 (26,3%), * 03 (22,4%), * 11 (22,4%), * 13 (21,7%)    and * 01 (13,9%). A high frequency in the distribution of a group of alleles was found. This fact could be related    to combinations that give evolutionary advantages against pathogens in our population.    <br> </font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>Key words:</strong> HLA, genes, allele, and population.</font></p> <hr>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">texto completo en pdf</font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>REFERENCIAS</strong></font></p>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Germain RH and Margulias DM. The biochemistry and cell biology of antigen processing and presentation Annual Review of Immunology. 1993; 11:403-450. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Unanue ER. Cellular studies on antigen presentation by class 2 molecules. Current Opinion in Immunology. 1992; 4:63-69. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. York IA and Rock KL. Antigen processing and presentation by class 1 mayor histocompatibility complex. Annual Review of Immunology. 1996; 14:339-396. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Zinkernagel RM and Doherty PC. MHC- restricted cytotoxic T cell studies on the biological role of polymorphic mayor transplantation antigen determining T cell restriction: Specificity, function, and responsiveness. Adv. Immunol. 1979; 27:52. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Tiiwari J and Terasaki PI. HLA and disease associations. New York: Sproger- Verlag; 1985. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Degos L. Repartation antropologique des genes HLA et dynamique des populations. In: Dausset J, Pla M., eds. HLA complexe majeur d2 histocompatibilite de l2 homme. Paris. Flammarion Medicine Sciences ;1989:215-232. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Chicz RM and Urtan RG. Analysis of MHC presented peptides: Application in autoimmunity and vaccine development. Immunology Today. 1994; 15(4):155-160. </font>    <P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Trowsdale J, Raugossis J and Cambell RD. Map of the human MHC. Immunology Today. 1991; 12:443-446. </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Arce S. Analisis mediante el empleo de la computaci&oacute;n electr&oacute;nica de los resultados del Workshop Internacional de Histocompatibilidad en Cuba. Sangre.1976; 21(2): 217-223. </font>    <P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Toledo I y Paradoa ML. Estudio de los ant&iacute;genos de clase 2 (HLA-DR) en Cuba [tesis de especialista]. La Habana: ICBP &quot;Victoria de Gir&oacute;n&quot;. ISCM; 1988. </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Diaz JW, Cheredeev AN. Distribution f HLA antigens in a Cuban population. Tissue Antigens. 1977; 9:71-79. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Miller SA, Dykes DD, Poleskey HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Rev. 1988; 16:215 </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Williams F, Mallon E, Middleton D. Development of PCR-SSOP for HLA-A typing of bone marrow registry donors. Tissue Antigens. 1997; 49:61-66. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Williams F, Meenagh A, Maxwell AP, Middleton D. Allele resolution of HLA- A using oligonucleotide probes in two _ stages. Tissue Antigens. 1999; 54:59-68. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Cavalli-Sforza LL, Bodmer WF. Human Evolution. In: The Genetics of Human Populations. San Francisco. W.H. Freeman. 1971; 683-752. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Parham P, Ohta T. Population biology of antigen presentation by MHC class I molecules: Science. 1996; 272:67. </font>    <P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Casta&ntilde;o AR y L&oacute;pez de Castro JA. Structure of the HLA- A* 0204 antigen, found in South American Indians. Spatial clustering of HLA-A2 subtype polymorphism. Immunogenetics. 1991; 34:281- 285. </font>     ]]></body>
<body><![CDATA[<!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Casta&ntilde;o AR y L&oacute;pez de Castro JA. Structure of the HLA-A2.5 subtype: further evidence for selectiondriven diversification of the HLA-A2 antigens. Immunogenetics. 1992; 35:345-347. </font>    <!-- ref --><P  ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Parham P. Evolution of class 1 HLA polymorphism, selection, and drift. In: Tsuji K, Aizawa M, Sasasuki T, (eds). HLA 1991: Proceedings of Eleventh International Histocompatibility Workshop and Conference Held in Yokohama, Japan, November 6-13, 1991. Oxford University Press: 1992; 538-547. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Williams F, Curran MD, Paradoa Perez M, Acosta A, Middleton D. Characterisation of a new HLA-B allele, HLA-B*0720, identified in the Cuban population. Tissue Antigens. &quot;En Prensa&quot;. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Hill AUS. HLA associations with Malaria in Africa. In Klein J and Klein D., eds. Molecular Biology of the MHC Heidelberg: Springer-Verlag; 1991:403. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Gorodezky C, Loon J, Mliterno R,Torres E, Gerbase de Lima M, Pelegrino J. HLA in some Latin American populations: Mexicans, Brazilians, Venezuelans and Uruguayans. In: Tsuji K, Aizawa M, Sasasuki T. (eds). HLA 1991: Proceedings of Eleventh International Histocompatibility Workshop and Conference Held in Yokohama, Japan, November 6-13, 1991. Oxford University press: 1992; 538-547. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. Bjorkman PJ, Saper MA, Samraouri B, Bennet WS, Strominger JL, and Wiley DC. The foreign antigen binding site and T cell recognition regions of class 1 histocompatibility antigens. Nature. 1987; 329:512. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24. Brown JH, Jerdetzky T, Saper MA, Samraouri B, Bjorkman PJ, and Wiley DC. A hypothetical model of the foreign antigen binding site of class 2 histocompatibility molecules. Nature. 1988; 332:845. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25. Klein J, Satta Y. and O2 h Uigin C. The molecular descent of the Major Histocompatibility Complex. Annu. Rev Immunol. 1993; 11:269-295. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26. Hughes AL, Nei, M. Pattern of nucleotide substitution at Mayor Histocompatibility Complex class 1 loci reveals overdominant selection. Nature. 1988; 335:167. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27.Hughes AL, Nei M. Nucleotide substitution at Mayor Histocompatibility Complex class 2 loci:evidence for overdominant selection. Proc Natl Acad. Sci. USA.1989; 86:958. </font>    <p>&nbsp; </p>     <p>&nbsp;</p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Germain]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Margulias]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The biochemistry and cell biology of antigen processing and presentation]]></article-title>
<source><![CDATA[Annual Review of Immunology]]></source>
<year>1993</year>
<volume>11</volume>
<page-range>403-450</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Unanue]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cellular studies on antigen presentation by class 2 molecules]]></article-title>
<source><![CDATA[Current Opinion in Immunology]]></source>
<year>1992</year>
<volume>4</volume>
<page-range>63-69</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[York]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
<name>
<surname><![CDATA[Rock]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Antigen processing and presentation by class 1 mayor histocompatibility complex]]></article-title>
<source><![CDATA[Annual Review of Immunology]]></source>
<year>1996</year>
<volume>14</volume>
<page-range>339-396</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zinkernagel]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Doherty]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[MHC restricted cytotoxic T cell studies on the biological role of polymorphic mayor transplantation antigen determining T cell restriction: Specificity, function, and responsiveness]]></article-title>
<source><![CDATA[Adv Immunol]]></source>
<year>1979</year>
<volume>27</volume>
<page-range>52</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tiiwari]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Terasaki]]></surname>
<given-names><![CDATA[PI]]></given-names>
</name>
</person-group>
<source><![CDATA[HLA and disease associations]]></source>
<year>1985</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Sproger- Verlag]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Degos]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Repartation antropologique des genes HLA et dynamique des populations]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Dausset]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pla]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[HLA complexe majeur d2 histocompatibilite de l2 homme]]></source>
<year>1989</year>
<page-range>215-232</page-range><publisher-loc><![CDATA[Paris ]]></publisher-loc>
<publisher-name><![CDATA[Flammarion Medicine Sciences]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chicz]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Urtan]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Analysis of MHC presented peptides: Application in autoimmunity and vaccine development]]></article-title>
<source><![CDATA[Immunology Today]]></source>
<year>1994</year>
<volume>15</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>155-160</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trowsdale]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Raugossis]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cambell]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Map of the human MHC]]></article-title>
<source><![CDATA[Immunology Today]]></source>
<year>1991</year>
<volume>12</volume>
<page-range>443-446</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arce]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Analisis mediante el empleo de la computación electrónica de los resultados del Workshop Internacional de Histocompatibilidad en Cuba]]></article-title>
<source><![CDATA[Sangre]]></source>
<year>1976</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>217-223</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toledo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Paradoa]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Cheredeev]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Distribution f HLA antigens in a Cuban population]]></article-title>
<source><![CDATA[Tissue Antigens.]]></source>
<year>1977</year>
<volume>9</volume>
<page-range>71-79</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Dykes]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Poleskey]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A simple salting out procedure for extracting DNA from human nucleated cells]]></article-title>
<source><![CDATA[Nucleic Acid Rev]]></source>
<year>1988</year>
<volume>16</volume>
<page-range>215</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mallon]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Middleton]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Development of PCR-SSOP for HLA-A typing of bone marrow registry donors]]></article-title>
<source><![CDATA[Tissue Antigens.]]></source>
<year>1997</year>
<volume>49</volume>
<page-range>61-66</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Meenagh]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Maxwell]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Middleton]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Allele resolution of HLA- A using oligonucleotide probes in two stages]]></article-title>
<source><![CDATA[Tissue Antigens]]></source>
<year>1999</year>
<volume>54</volume>
<page-range>59-68</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cavalli-Sforza]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Bodmer]]></surname>
<given-names><![CDATA[WF]]></given-names>
</name>
</person-group>
<source><![CDATA[The Genetics of Human Populations]]></source>
<year>1971</year>
<page-range>683-752</page-range><publisher-loc><![CDATA[San Francisco ]]></publisher-loc>
<publisher-name><![CDATA[W.H. Freeman]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parham]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ohta]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Population biology of antigen presentation by MHC class I molecules]]></article-title>
<source><![CDATA[Science]]></source>
<year>1996</year>
<volume>272</volume>
<page-range>67</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castaño]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[López de Castro]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Structure of the HLA- A 0204 antigen, found in South American Indians: Spatial clustering of HLA-A2 subtype polymorphism]]></article-title>
<source><![CDATA[Immunogenetics]]></source>
<year>1991</year>
<volume>34</volume>
<page-range>281- 285</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castaño]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[López de Castro]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Structure of the HLA-A2: 5 subtype:further evidence for selectiondriven diversification of the HLA-A2 antigens]]></article-title>
<source><![CDATA[Immunogenetics]]></source>
<year>1992</year>
<volume>35</volume>
<page-range>345-347</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parham]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Evolution of class 1 HLA polymorphism, selection, and drift]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Tsuji]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Aizawa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sasasuki]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[]]></source>
<year>1992</year>
<conf-name><![CDATA[Eleventh HLA 1991]]></conf-name>
<conf-date>November 6-13, 1991</conf-date>
<conf-loc>Yokohama </conf-loc>
<page-range>538-547</page-range><publisher-name><![CDATA[Oxford University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Curran]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Paradoa Perez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Middleton]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Characterisation of a new HLA-B allele, HLA-B*0720, identified in the Cuban population]]></article-title>
<source><![CDATA[Tissue Antigens]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hill]]></surname>
<given-names><![CDATA[AUS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[HLA associations with Malaria in Africa]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Molecular Biology of the MHC Heidelberg]]></source>
<year>1991</year>
<page-range>403</page-range><publisher-name><![CDATA[Springer-Verlag]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gorodezky]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Loon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mliterno]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gerbase de Lima]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pelegrino]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[HLA in some Latin American populations: Mexicans, Brazilians, Venezuelans and Uruguayans]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Tsuji]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Aizawa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sasasuki]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[]]></source>
<year>1992</year>
<conf-name><![CDATA[ HLA 1991: Proceedings of Eleventh International Histocompatibility Workshop and Conference Held in Yokohama,]]></conf-name>
<conf-date>November 6-13, 1991</conf-date>
<conf-loc> </conf-loc>
<page-range>538-547</page-range><publisher-name><![CDATA[Oxford University press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bjorkman]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Saper]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Samraouri]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bennet]]></surname>
<given-names><![CDATA[WS]]></given-names>
</name>
<name>
<surname><![CDATA[Strominger]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Wiley]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The foreign antigen binding site and T cell recognition regions of class 1 histocompatibility antigens]]></article-title>
<source><![CDATA[Nature]]></source>
<year>1987</year>
<volume>329</volume>
<page-range>512</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Jerdetzky]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Saper]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Samraouri]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bjorkman]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Wiley]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A hypothetical model of the foreign antigen binding site of class 2 histocompatibility molecules]]></article-title>
<source><![CDATA[Nature]]></source>
<year>1988</year>
<volume>332</volume>
<page-range>845</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Satta]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[O2 h Uigin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The molecular descent of the Major Histocompatibility Complex]]></article-title>
<source><![CDATA[Annu Rev Immunol]]></source>
<year>1993</year>
<volume>11</volume>
<page-range>269-295</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Nei]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pattern of nucleotide substitution at Mayor Histocompatibility Complex class 1 loci reveals overdominant selection]]></article-title>
<source><![CDATA[Nature]]></source>
<year>1988</year>
<volume>335</volume>
<page-range>167</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Nei]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Nucleotide substitution at Mayor Histocompatibility Complex class 2 loci: evidence for overdominant selection]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>1989</year>
<volume>86</volume>
<page-range>958</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
